NCT05221099

Brief Summary

Various clinical scales are available to investigate balance impairment, Mini-BESTest is one of them. Thus, this study aims to translate the Mini-BESTest into Urdu and investigate its psychometric properties in the Pakistani Parkinson's population with dynamic balance impairment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 1, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2022

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2022

Completed
Last Updated

March 10, 2022

Status Verified

March 1, 2022

Enrollment Period

8 months

First QC Date

February 1, 2022

Last Update Submit

March 8, 2022

Conditions

Keywords

Balance; Mini-BESTest; Parkinson's ; reliability; validity

Outcome Measures

Primary Outcomes (3)

  • Mini-BESTest Scale

    A measuring instrument for the evaluation of dynamic balance is the Mini-BESTest Scale. Each item is scored from 0 to 2 , higher score 2 means better balance performance and 0 showing worst balance performance . Mini-BESTest 28 is the highest result possible

    1st day

  • Berg Balance Scale

    The Berg Balance Scale is an objective assessment of balance performance based on 14 items common to everyday activities. It is a 14 items scale that rates 0 (unable to perform) to 4 (normal performance) for each item. The total score is 56 points. Higher score higher balance ability.

    1st day

  • Brief -BESTest Scale

    The Brief -BESTest Scale is a shorter version of the BEStest Scale and takes less time to administer. It consist of eight items from six section . Each item is scored from 0 to 3, higher score means better balance performance. All items scores are summed to obtain the total score which ranges from 0 to 24.

    1st day

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The incidence of Parkinson disease increases by age especially after the age of 60 As we know equilibrium and postural control are essential for everyday work so postural instability, freezing of gait, impaired anticipatory and reactive balance, impaired cognition ,reduced leg muscle strength, reduced proprioception, and frontal lobe impairment are major cause of balance impairment and falls in persons with Parkinson disease and falling puts persons with Parkinson disease at a higher risk of fractures, soft tissue injury, immobilization, depression, daily activity restriction, and mortality

You may qualify if:

  • All persons with Parkinson disease and ability to follow commands were included in the study.
  • living independently in the community
  • able to walk 6 m independently
  • willing to participate in the study.

You may not qualify if:

  • History of other neurological disorders
  • Musculoskeletal damage which affects walking ability
  • Presence of serious medical condition
  • History of surgical treatments for Parkinson disease
  • Not willing to participate in the study
  • history of faint, vertigo, dizziness,or taking medications which can cause dizziness
  • history of any medical condition which can affect balance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ripah International University

Faisalabad, Punjab Province, 38000, Pakistan

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Muhammad Kashif

    Riphah International University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2022

First Posted

February 2, 2022

Study Start

May 30, 2021

Primary Completion

February 5, 2022

Study Completion

February 15, 2022

Last Updated

March 10, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations